Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-NTRK3 positive metastatic salivary secretory carcinoma: A case series.

Yokota, Tomoya; Yukino, Hiroki; Doi, Mihoko; Ohori, Hisatsugu

Yokota, Tomoya; Yukino, Hiroki; Doi, Mihoko; Ohori, Hisatsugu.

Affiliation

Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Yukino H; Department of Otolaryngology-Head and Neck Surgery, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Doi M; Division of Genomic Medicine and Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Ohori H; Division of Medical Oncology, Japanese Red Cross Ishinomaki Hospital, Miyagi, Japan.

Head Neck ; 45(5): E10-E15, 2023 05.

Article de En | MEDLINE | ID: mdl-36924196

Sujet(s)
Mots clés

ETV6-NTRK3; complete response; entrectinib; molecular screening; salivary secretory carcinoma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tropomyosine / Carcinomes Type d'étude: Clinical_trials Limites: Adult / Child / Humans Langue: En Journal: Head Neck Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google